Clinical Trials Browser

Phase 2/3 × OTHER × EC regimen × Clear all

NCT03992911 2019-06-20

Safety and Efficacy of FOLFSIM Plus Toripalimab in the Treatment of Advanced or Metastatic Neuroendocrine Carcinoma

Phase 2/3 Unknown

Carcinoma, Neuroendocrine

NCT01204437 2016-02-10

ICE-II

Phase 2/3 Completed

Breast Neoplasms